Medical imaging AI company receives approval for CINA-CSpine algorithm enabling detection and triage of cervical spine fractures.
Medical imaging AI company Avicenna.AI recently announced that it has received 510(k) clearance from the US Food and Drug Administration for its CINA-CSpine tool. Using a combination of deep learning and machine learning technologies, the company develops AI solutions that automatically detect and prioritize life-threatening conditions within seconds, assess them for severity, and seamlessly notify clinicians.
CINA-CSpine is an AI tool designed to support the detection and triage of cervical spine fractures from CT images. Commonly caused by traumatic injury, a cervical spine fracture is a break in one or more of the seven vertebrae in the neck that can lead to spinal cord injury, resulting in neurological damage or even paralysis.
While the prognosis for cervical spine fractures depends on the severity of the injury, the timeliness of treatment is key, so prompt detection and appropriate treatment are crucial for optimizing outcomes and minimizing long-term complications. CINA-CSpine automatically flags suspected positive findings compatible with acute cervical spine fractures, seamlessly alerting radiologists through their existing systems.
“Cervical spine fractures are serious injuries that require prompt and appropriate medical attention, especially if the spinal cord is involved, so accurate diagnosis is essential,” said Cyril Di Grandi, co-founder and CEO of Avicenna.AI. “With CINA-CSpine, we aim to help reduce the delay between scan and interpretation, which is critical in the treatment of this condition.”
In addition, while m